Trials

Researchers at King’s have conducted 4 studies over 5 years across over 400 healthy participants and patients, into the efficacy of Vstore as a cognitive assessment tool. They have concluded that VStore is strongly associated with functional capacity, as required by the FDA, and can detect the earliest signs of cognitive decline. It is sensitive to age-related decline. VStore can differentiate between clinical and healthy populations and VStore can be reconfigured over multiple levels and for multiple tasks to avoid repetition learning.